RPID compared with KLRA: revenue, margins and what each company keeps, and the suppliers and customers both name

RPIDRapid Micro Biosystems, Inc.

Mkt capRevenueRevenue

KLRAKailera Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

RPIDRapid Micro Biosystems, Inc.

KLRAKailera Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

RPID1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−16.83%—

KLRA1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−3.34%—

= impliedRPID realized, solidKLRA realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

RPIDRapid Micro Biosystems, Inc.

0.68▼−3.81%

Mkt cap$35.3MRevenue$8MQ2 FY26Revenue$34MFY25

KLRAKailera Therapeutics, Inc.

12.65▲+4.07%

Regular sessionNov 3 '26

Mkt cap$1.3BRevenue—Revenue—

Compare

Regular sessionNov 3 '26

RPIDRapid Micro Biosystems, Inc.

KLRAKailera Therapeutics, Inc.

0.68▼−3.81%

Price

12.65▲+4.07%

$35.3M

Mkt cap

$1.3B

Q2 FY26$8M

Revenue

—

FY25$34M

Revenue

—

RPID0.68▼−3.81%vsKLRA12.65▲+4.07%Regular sessionNov 3 '26